Search research articles
Contact Us
Filters
Showing results (1501-1510 of 1,553) with videos related to
Page
of 156
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2025
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
BMC Cancer
|
October 4, 2025
Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers
Ying Liu, Wei He, Qi Wu, et al.
American Journal of Hematology
|
June 23, 2026
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis
Jing Li, Chenqi Yu, Jinghua Wang, et al.
The Lancet. Oncology
|
September 23, 2020
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
Jianming Xu, Lin Shen, Zhiwei Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2024
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
Panpan Zhang, Si Shi, Jianming Xu, et al.
Science (New York, N.Y.)
|
June 1, 2023
Rhythmic cilia changes support SCN neuron coherence in circadian clock
Hai-Qing Tu, Sen Li, Yu-Ling Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
Science Advances
|
March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
Ziyu Li, Xiangyu Gao, Xinxin Peng, et al.
JAMA Network Open
|
August 16, 2021
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study
Linhong Wang, Wei Yu, Xiangjun Yin, et al.
Page
of 156
Search research articles
Search
Showing results (1501-1510 of 1,553) with videos related to
Sort By:
Page
of 156
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 25, 2021
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
Feng-Hua Wang, Xiao-Li Wei, Jifeng Feng, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 30, 2025
Surufatinib in advanced neuroendocrine tumours: Final overall survival from two randomised, double-blind, placebo-controlled phase 3 studies (SANET-ep and SANET-p)
Jianming Xu, Lin Shen, Jie Li, et al.
BMC Cancer
|
October 4, 2025
Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers
Ying Liu, Wei He, Qi Wu, et al.
American Journal of Hematology
|
June 23, 2026
A Multicenter National Study of AL Amyloidosis in China: Insights Into Real-World Diagnosis, Treatment, and Prognosis
Jing Li, Chenqi Yu, Jinghua Wang, et al.
The Lancet. Oncology
|
September 23, 2020
Surufatinib in advanced extrapancreatic neuroendocrine tumours (SANET-ep): a randomised, double-blind, placebo-controlled, phase 3 study
Jianming Xu, Lin Shen, Zhiwei Zhou, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 18, 2024
Surufatinib plus toripalimab in patients with advanced neuroendocrine tumours and neuroendocrine carcinomas: An open-label, single-arm, multi-cohort phase II trial
Panpan Zhang, Si Shi, Jianming Xu, et al.
Science (New York, N.Y.)
|
June 1, 2023
Rhythmic cilia changes support SCN neuron coherence in circadian clock
Hai-Qing Tu, Sen Li, Yu-Ling Xu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 30, 2025
A First-in-Human Study of Givastomig, a CLDN18.2 and 4-1BB Bispecific Antibody, as Monotherapy in Patients with CLDN18.2-Positive Advanced or Metastatic Solid Tumors
Geoffrey Ku, Lin Shen, Farshid Dayyani, et al.
Science Advances
|
March 6, 2020
Multi-omics characterization of molecular features of gastric cancer correlated with response to neoadjuvant chemotherapy
Ziyu Li, Xiangyu Gao, Xinxin Peng, et al.
JAMA Network Open
|
August 16, 2021
Prevalence of Osteoporosis and Fracture in China: The China Osteoporosis Prevalence Study
Linhong Wang, Wei Yu, Xiangjun Yin, et al.
Page
of 156